Welcome : Guest

BTG Plc (UK) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about BTG Plc, which is principally involved in the Manufacture and Distribution of Interventional Medicine; Specialty Pharmaceuticals; and Licensing. Illustrated with 162 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-08733
Price: $3500
Company Type: Public
Pages: 166
Date: October 2015
Market Data Tables: 162

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: BTG Plc’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for USA, Europe and Others......4
Table 2: BTG Plc’s Sales by Product Segment Worldwide (2014-2015) in Percentage for Interventional Medicine, Specialty Pharmaceuticals and Licensing......5
Pharmaceuticals......6
Table 3: Pharmaceuticals Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Asia, Africa, and Australasia, European Union, Japan, Latin America, and North America......6
Table 4: Pharmaceuticals Sales by Category Worldwide (2014) - Percentage Market Share Breakdown by Value for Active Pharmaceutical Ingredients, Contrast Products, Radiopharmaceuticals, and Specialty Pharmaceuticals......7
Table 5: Pharmaceuticals Market by Region in European Union (2014) - Percentage Share Breakdown by Value Sales for France, Germany, Great Britain, Italy, Spain, and Others......8
Table 6: Pharmaceutical Drugs Market by Category in Germany (2014) - Percentage Share Breakdown by Value Sales for Biopharmaceuticals, Pharma Drugs for Human Use, and Others......9
Table 7: Pharmaceuticals by Therapeutic Area in China (2014) - Percentage Market Share Breakdown by Value Sales for Alimentary & Metabolism, Anti-Infective, Cardiovascular, Central Nervous System, Neoplasm, and Others......10
Table 8: New Pharmaceutical Licensed Drugs Market by Indication Worldwide (2014) - Percentage Share Breakdown by Value Sales for AIDS, Diabetes, Diabetes (DPP4), Hepatitis B, Hypertension, and Others......11
Table 9: New Pharmaceutical Licensed Drugs Market by Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for Humulin, Trajenta, Truvada, Twynsta, Viread, and Others......12
Table 10: Research & Development Spending in Pharmaceuticals by Category Worldwide (2014) - Percentage Market Share Breakdown by Value for Approval, Discovery, Pre-Clinical, Phase I, Phase II, Phase III, Phase IV, and Others......13
Table 11: Speciality Pharmaceuticals Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......14
Table 12: Pharmaceutical Market by Category in Canada (2015)-Percentage Share Breakdown by Value for Hospital and Retail......15
Table 13: Pharmaceutical Market by Category in Vietnam (2015)-Percentage Share Breakdown by Value for Generic Drugs, Patented Drugs and Others......16
Table 14: Pharmaceutical Market by Country in Europe (2014) - Percentage Share Breakdown by Value Sales for France, Germany, Greece, Italy, Spain, UK, and Others......17
Table 15: Pharmaceutical Market by Country Worldwide (2015)-Percentage Share Breakdown by Value for China, Japan, USA and Others......18
Table 16: Pharmaceutical Market by Region in Brazil (2015) - Percentage Share Breakdown by Value Sales for Mid-West, North, Northeast, São Paulo, South, and Others......19
Table 17: Pharmaceutical Market by Region in Latin America (2015)-Percentage Share Breakdown by Value for Argentina, Brazil, Mexico, Venezuela and Others......20
Table 18: Pharmaceutical Prescription Segment Market by Category in Indonesia (2015)-Percentage Share Breakdown by Value for Unbranded Generic and Other Prescription......21
Table 19: Pharmaceuticals Market by Category Worldwide (2015)-Percentage Share Breakdown by Value for Biologics and Chemical Synthetic and Others......22
Table 20: Pharmaceuticals Market by Product in the US (2014) - Percentage Share Breakdown by Value Sales for Abilify, AdvairDiskus, Crestor, Cymbalta, Enbrel, Humira, Nexium, Remicade, and Others......23
Table 21: Pharmaceuticals Market by Therapeutic Area in China (2014) - Percentage Share Breakdown by Value Sales for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular Diseases, Musculo-Skeletal System, Nervous System, Oncology, Respiratory System, Systemic Anti- Infective, and Others......24
Table 22: Pharmaceuticals Market by Therapeutic Area in China (2015) - Percentage Share Breakdown by Value for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular System, Nervous System, Oncology and Immunomodulating Agents, Systemic Anti-infectives, Musculo-Skeletal System and Others......25
Table 23: Pharmaceuticals Prescription Market by Product in the US (2014) - Percentage Share Breakdown by Value Sales for Amlodipine, Hydrocodone/Acetaminophen, Levothyroxine, Lisinopril, Metformin, Metoprolol, Omeprazole, Salbutamol, Simvastatin, and Others......26
Table 24: Generic Pharmaceuticals Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Diabetes, Hormonal Drugs, Oncology, Respiratory, Rheumatology, and Others......27
Prescription Drugs......28
Table 25: Prescription Drugs Market in the US (2014) in US$ Million......28
e-Prescriptions......29
Table 26: e-Prescription Adoption by Chain Pharmacies in US (2010-2014) (in Thousands)......29
Table 27: e-Prescription Adoption Rates by Small Practitioners in the US (%) - 2014......30
Table 28: e-Prescription Adoption Rates by Specialization in the US (%) - 2014......31
Table 29: US States Ranked by Safe e-Prescription Adoption Rates - 2014......32
Table 30: Number of e-Prescriptions (2010-2014) Routing in Million......33
Acne Drugs......34
Table 31: Acne Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Isotretinoin, Topicals (Retinoid/Antibiotics), Oral Antibiotics, and Others......34
Table 32: Acne Drugs Market by Segments in the US (2015)-Percentage Share Breakdown by Volume for Orals and Topicals......35
Antibiotics......36
Table 33: Antibiotics Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......36
Table 34: Antibiotics Market by Category in China (2014) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......37
Anticoagulants......38
Table 35: Anticoagulant Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Heparin, Low-Molecular-Weight Heparin (LMWH), Novel Oral Anticoagulants, Warfarin, and Other Injectable Anticoagulants......38
Table 36: Anticoagulation Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Direct Thrombin Inhibitors (DTI), Low-Molecular-Weight Heparin (LMWH), Unfractionated Heparin (UFH), Vitamin K Antagonists (VKA) and Others......39
Antipsychotic Drugs......40
Table 37: Antipsychotic Drugs Market by Disorder in the US (2014) - Percentage Breakdown by Value for Anxiety, Bipolar, Disorder, Major, Depression, Schizoaffective Disorder, Schizophrenia, and Other Indications......40
Table 38: New Prescription Market for Atypical Antipsychotic Drugs in the US (2014) - Percentage Share Breakdown by Value Sales for Abilify (Otsuka/ Bristol-Myers Squibb Company), Fanapt (Novartis), Geodon (Pfizer, Inc.), Invega (Johnson & Johnson), Latuda (Sunovion), Olanzapine (Generic Zyprexa), Risperidone (Generic Risperdal), Saphris (Merck & Company, Inc.), Seroquel (AstraZeneca Plc), and Zyprexa (Eli Lilly and Company)......41
Antihypertensive Drugs......42
Table 39: Antihypertensive Drugs Market by Product in China (2105)-Percentage Share Breakdown by Value for Angiotensin II Receptor Blockers (ARBs), Beta Blocker, Calcium Channel Blocker and Others......42
Cancer Drugs......43
Table 40: Oncology Drug Market by Region Worldwide (2015)-Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......43
Table 41: Anti-Cancer Drugs Market by Product Type in China (2014) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......44
Table 42: Anti-Cancer Drugs Market by Type in China (2014) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......45
Table 43: Cancer Care Expenditure by Site Worldwide (2014) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others*......46
Table 44: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......47
Table 45: Cancer Market by Type in China (2015)-Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......48
Table 46: Cancer-Associated Mucositis Market by Activity Worldwide (2015)-Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......49
Table 47: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......50
Table 48: Skin Cancer by Type Worldwide (2014) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......51
Table 49: Hematological Cancer by Category Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......52
Table 50: Clinical Oncology Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......53
Table 51: Hereditary Oncology Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......54
Table 52: Oncology Genomics (Clinical, Hereditary, and Molecular Monitoring) Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Us, and Others......55
Table 53: Oncology Genomics Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......56
Table 54: Oncology Genomics Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......57
Table 55: Oncology Market by Category in China (2015)-Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......58
Table 56: Oncology Market by Product Segment Worldwide (2014) - Percentage Breakdown by Value for Dialysis Catheters, Enteral Feeding, Peripherally Inserted Central Catheters, Ports, Ultrasound, and Others......59
CNS Drugs......60
Table 57: Central Nervous System (CNS) Market by Segment Worldwide (2015)-Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......60
Table 58: Central Nervous System Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......61
COPD Drugs......62
Table 59: Chronic Obstructive Pulmonary Disease (COPD) and Asthma Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Flixotide and Flovent, Seretide and Advair, Spiriva, Symbicort, Xolair, and Others......62
Table 60: Chronic Obstructive Pulmonary Disease (COPD) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Long Acting Muscarinic Antagonists (LAMA), Long Acting Muscarinic Antagonists (LAMA) and Long Acting β2-Agonists (LABA), and Long Acting β2-Agonists (LABA) and Inhaled Corticosteroid (ICS)......63
Diabetes Drugs......64
Table 61: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......64
Table 62: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......65
Table 63: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......66
Table 64: Diabetes Market by Segment in the US (2015)-Percentage Share Breakdown by Value for Anti-Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Pres cription Medication and Others......67
Table 65: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......68
Table 66: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type‐1 Diabetes, Insulin Type‐2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP‐1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others* (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......69
Table 67: Diabetes/Metabolic Drugs Market by Category Worldwide (2014) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......70
Table 68: Antidiabetes Molecules Market by Drug Worldwide (2015)-Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......71
Table 69: Anti-Diabetic Drug Market by Treatment Class Worldwide (2014) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......72
Table 70: Anti-Diabetic Drugs Market by Category in China (2015)-Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......73
Table 71: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015)-Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......74
Table 72: No. of Diabetes Patients by Medication in the US (2014) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......75
Table 73: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2014)-Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......76
Glaucoma Drugs......77
Table 74: Glaucoma Disease Market for Non Prostaglandin Analogs (Non-PGAs) by Drug Worldwide (2015)-Percentage Share Breakdown by Value for Alpha Agonist, Beta Blockers (alone), Beta Blockers (combo), Canbone Anymore and Others......77
Table 75: Glaucoma Disease Market for Prostaglandin Analogs (PGAs) by Drug Worldwide (2015)-Percentage Share Breakdown by Value for Latanoprost, Lumigan, Travatan and Others......78
Table 76: Glaucoma Market by Product in the US (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blocker, Beta Blocker Fixed Combo, Bimatoprost (Lumigan), Carbonic Anhydrase Inhibitor, Latanoprost (Xalatan, Generics), Travoprost (Travatan), and Others......79
Insulin......80
Table 77: Insulin Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Aspart (Novolog), Detemir (Levemir), Glargine (Lantus), Glulisine (Apidra), Lispro (Humalog) and Rh Insulin......80
Table 78: Insulin Market by Generation in China (2014) - Percentage Share Breakdown by Value for 1st Generation, 2nd Generation, and 3rd Generation......81
Table 79: Insulin Market by Product Type in the US (2015)-Percentage Share Breakdown by Value for Fast-Acting, Human, Long-Acting and Mix......82
Table 80: Insulin Market by Type Worldwide (2015)-Percentage Share Breakdown by Value for Basal Insulins, Prandial Insulins and Pre-Mixed Insulin......83
Table 81: Insulin Market by Type Worldwide (2015)-Percentage Share Breakdown by Value for Fast Acting, Long Acting and Premix......84
Pulmonary Arterial Hypertension (PAH) Drugs......85
Table 82: Pulmonary Arterial Hypertension (PAH) Treatment by Drug Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Adcirca, Letairis/Volibris, Remodulin, Revatio, Tracleer, Tyvaso and Ventavis......85
Table 83: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in Europe (2014) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......86
Table 84: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in the US (2014) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......87
Table 85: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy Worldwide (2014) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......88
Table 86: Pulmonary Arterial Hypertension (PAH) Treatment with Macitentan Drug by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for Japan, US and Rest of World......89
Table 87: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in Europe (2014) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......90
Table 88: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in the US (2014) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......91
Table 89: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type Worldwide (2014) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......92
Urinary Incontinence Drugs......93
Table 90: Urinary Incontinence Drugs Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Detrol, Detrol LA (PFE), Newer Therapies (ACT, AGN, PFE), Oxybutinin, and Others (Generics)......93
Table 91: Urinary Incontinence Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Anticholinergic Agents, and Newer Therapies......94
Table 92: Urology Market by Category in North America and Europe (2014) - Percentage Share Breakdown by Value for Erectile Dysfunction, Gynaecological Pain, Hypogonadism, Interstitial Cystitis / Painful Bladder Syndrome, Premature Ejaculation, Urinary Incontinence, and Urological Cancers......95
Table 93: Urology Surgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for < 15 years, 15-44 Years, 45-64 Years, and 65+ Years......96
Drug Eluting Stents (DES)......97
Table 94: Drug-Eluting Stent (DES) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for ABT Xience, MDT Endeavor and Resolute, and BSX......97
Table 95: Coronary Stent Market by Drug Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Bare Metal Stent (BMS), and Drug Eluting Stent (DES)......98
Table 96: Drug Eluting Stents (DES) Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for China, Europe, Japan, US, and Others......99
Other Drugs......100
Table 97: 5-HT3 Antagonist Market by Drug Worldwide (2015)-Percentage Share Breakdown by Value for GRANISETRON, ONDANSETRON AND PALONOSETRON (ALOXI)......100
Table 98: Anatomical Therapeutic Chemical (ATC-3) Indications Market in Germany (2014) - Percentage Share Breakdown by Value Sales for A10C Human Insulin and Analogs, C09D Angiotensin II Antagonists, L01X Other Antineoplastic Agents, L03B Interferons, L04B Anti-TNF Preparations, L04X Other Immunosuppressants, N02A Analgesics, Narcotics, N03A Antiepileptics, N05A Antipsychotics, T02D Diabetes Tests, and Others......101
Table 99: Anatomical Therapeutic Chemical (ATC-3) Indications Market in Germany (2014) - Percentage Share Breakdown by Volume Sales for A02B Ulcer Treatments, B01C Anti-Platelet Treatments, C07A Beta-Blockers, Pure, M01A Anti-Phlog/ Anti-Rheumatic, Non-Steroid, M02A Anti-Rheumatic and Analgesics, Topical, N02B Other Analgesics, R01A Nasal Preparations, Topical, R02A Throat Preparations, R05C Expectorants without Anti-Infectants, V03X Other Therapeutic Preparations, and Others......102
Table 100: Plasma Products Consumption by Type in the US (2014) - Percentage Share Breakdown by Volume for Albumin, Factor IX (Plasma), Factor VIII, Hyperimmunes (IM&IV), and Intravenous Immunoglobulin (IVIG), and Others......103
Table 101: Steroids Market by Nasal Drug in the UK (2015) - Percentage Share Breakdown by Value for Flonase/Flutic Asone, Nasacort, Nasonex, Omnaris, Rhinocort and Veramyst......104
Table 102: Hospital Drug Market by Segment in China (2015)-Percentage Share Breakdown by Value for Anti-Infection, Cardio-Cerebral Vascular, Digest, Neurology, Oncology and Others......105
Table 103: Cardiovascular Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......106
Pharmaceuticals......107
Table 104: Leading Pharmaceuticals Suppliers to Germany by Region Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Belgium, France, Great Britain, Ireland, Italy, Netherlands, Spain, Sweden, Switzerland, USA, and Others......107
Table 105: Market Shares of Leading Preclinical Pharmaceutical Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Charles River Laboratories International, Inc. (CRL), Covance, Inc. (CVD), Pharmaceutical Product Development Inc. (PPDI), Wuxi Pharmatech (Cayman) Inc. (WX), and Others......108
Table 106: Market Shares of Leading Pharmaceutical Companies in Australia (2015)-Percentage Share Breakdown by Value for AstraZeneca, Pfizer, Inc. and Others......109
Table 107: Market Shares of Leading Pharmaceutical Companies in India (2014) - Percentage Breakdown by Value for Abbott India Limited, Alembic Pharmaceuticals Limited, Alkem Laboratories, Aristo Pharmaceuticals Pvt Ltd., Cadila Pharmaceuticals Limited., Cipla Global Limited, Dr. Reddy's Laboratories., Emcure Pharmaceuticals Ltd., FDC Limited., GlaxoSmithKline Pharmaceuticals Ltd., Glenmark Pharmaceuticals, Intas Pharmaceuticals limited, Lupin Limited, Macleods Pharmaceuticals Ltd., Mankind Pharma, Micro Labs Ltd., Novartis AG, Pfizer Limited, India., Ranbaxy Laboratories Limited, Sanofi India Limited, Sun India Pharmacy (P) Ltd., Torrent Pharmaceuticals Limited., Unichem Laboratories, USV Limited., Wockhardt Ltd., and Others......110
Cancer Drugs......111
Table 108: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......111
Table 109: Market Shares of Leading Oncology Drug Manufacturers in China (2015)-Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......112
Table 110: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......113
Gastrointestinal Drugs......114
Table 111: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Torrent Pharmaceuticals Ltd, and Others......114
Table 112: Market Shares of Leading Gastrointestinal Remedy Product Producers by Value Sales in the US OTC Market (2014) - Percentage Breakdown for GlaxoSmithKline plc., Johnson & Johnson, Novartis A G, Prestige Brands Holdings, Inc., Procter & Gamble Co., Private Label and Others......115
Table 113: Market Shares of Leading Gastrointestinal, Ulcer Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & JohnsonPfizer, Inc., and Others......116
Generic Drugs......117
Table 114: Market Shares of Leading Generic Pharmaceutical Companies by Value Sales in India (2014) - Percentage Breakdown for Abbott India Ltd., Alkem Laboratories Ltd, Cipla Ltd., GlaxoSmithKline Pharmaceuticals Ltd. (GSK), Lupin Ltd., Mankind Pharma, Pfizer Ltd., Ranbaxy Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Zydus Cadila and Others......117
Table 115: Market Shares of Leading Generics Manufacturers by Value Sales in South Africa (2014) - Percentage Breakdown for Adcock Ingram, Aspen Pharmacare Holdings Limited, Cipla Global Limited, Lupin Limited, Novartis International AG, Sanofi S.A., and Others......118
Table 116: Market Shares of Leading Generics Manufacturers in Australia (2015)-Percentage Share Breakdown by Value for Apotex, Inc., Aspen Pharmaceutical Holdings Ltd., Mylan, Inc., Sandoz and Others......119
Table 117: Market Shares of Leading Generics Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Ems Sigma Pharma Group, Eurofarma Laboratórios, Hypermarcas S.A., Pfizer, Inc., Sanofi - Medley Indústria Farmacêutica Ltda and Others......120
Hepatitis Drugs......121
Table 118: Market Shares of Leading Hepatitis A and Typhoid Polysaccharide Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hepatyrix), and Others......121
Table 119: Market Shares of Leading Hepatitis A Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Havrix), and Others......122
Table 120: Market Shares of Leading Hepatitis B (Recombinant) Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Engerix (GlaxoSmithKline Plc), and Others......123
Table 121: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales in Korea (2014) - Percentage Breakdown for Bemis Company, Inc. (BMS), Bukwang Pharmaceutical Co., Ltd (Levovir), GlaxoSmithKline Plc (Hopsera, Zeffix), Novartis International AG (Sebivo), and Others......124
Table 122: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bemis Company, Inc.(Baraclude), F. Hoffmann-La Roche AG (Pegasys), GlaxoSmithKline Plc (Hepsera, Zeffix), and Novartis International AG (Sebivo)......125
Table 123: Market Shares of Leading Hepatitis B Immune Globulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Nanyue Fuel Injection Systems Co, Ltd., Ningbo Boya Medical Equipment Co, Ltd., Shuyang Group, Tonrol Biopharm Co, Ltd., and Others......126
Table 124: Market Shares of Leading Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Co (BMY), GlaxoSmithKline Plc (GSK), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Vertex Pharmaceuticals, Inc. (VRTX), and Others......127
Injectables......128
Table 125: Market Shares of Leading Injectable Manufacturers by Value Sales in France (2014) - Percentage Breakdown for Aguettant Limited, Baxter International, Inc., B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., Lake Forest Park Medical Clinic (LFP), Mylan Laboratories, Inc., Novartis International AG (Sandoz), Laboratoires PANPHARMA S.A., Sanofi S.A., and Others......128
Table 126: Market Shares of Leading Injectable Manufacturers by Value Sales in Germany (2014) - Percentage Breakdown for AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Medac GmbH, Novartis International AG (Sandoz), Sanofi S.A.,Teva Pharmaceutical Industries Ltd. and Others......129
Table 127: Market Shares of Leading Injectable Manufacturers by Value Sales in Italy (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Hospira, Inc., Johnson & Johnson, KEDRION GROUP S.p.A., Novartis International AG (Sandoz), Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd. and Others......130
Table 128: Market Shares of Leading Injectable Manufacturers by Value Sales in Spain (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Ges Genericos Españoles Laboratorio S.A., Grifols, S.A, Hospira, Inc., Johnson & Johnson, Normon S.A., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......131
Table 129: Market Shares of Leading Injectable Manufacturers by Value Sales in the UK (2014) - Percentage Breakdown for Actavis Plc (Watson), AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Hospira, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......132
Table 130: Market Shares of Leading Generic Injectable Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Fresenius SE & Co., Hikma Pharmaceuticals, Hospira, Inc., Luitpold Pharmaceuticals, Inc. and Others......133
Insulin......134
Table 131: Market Shares of Leading Insulin Companies in China (2014) - Percentage Share Breakdown by Value for Eli Lilly and Company, GanLee Pharmaceutical Co., Ltd., Novo Nordisk, Sanofi S.A., Shanghai Fosun Pharmaceutical Group Co, Ltd., United Laboratories International Holdings Ltd. (The), Tonghua Dongbao Pharmaceutical Co., Ltd., and Others......134
Table 132: Market Shares of Leading Insulin Companies in China (2015)-Percentage Share Breakdown by Volume for Novo Nordisk, Tonghua Dongbao Pharmaceutical Co., Ltd., Wanbang Biopharmaceuticals Co., Ltd. and Others......135
Table 133: Market Shares of Leading Insulin Companies in Europe (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S and Others......136
Table 134: Market Shares of Leading Insulin Companies in Japan and Korea (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S and Others......137
Table 135: Market Shares of Leading Insulin Companies in North America (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S and Others......138
Table 136: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A. and Others......139
Table 137: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Volume Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A. and Others......140
Table 138: Market Shares of Leading Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Cadila Pharmaceuticals Limited, Eli Lilly and Company India Pvt. Ltd., Lupin Pharmaceuticals, Inc., Novo Nordisk India Limited, Pfizer India Limited, Ranbaxy Laboratories Limited, Sanofi India Limited, Shreya Life Sciences Pvt. Ltd, USV Limited and Wockhardt Ltd.......141
Table 139: Market Shares of Leading Long-Acting Insulin Producing Companies Worldwide (2015)-Percentage Share Breakdown by Value for Sanofi S.A., Wockhardt Ltd., and Others......142
Table 140: Market Shares of Leading Second-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Novo Nordisk, The United Laboratories International Holdings, Ltd., and Tonghua Dongbao Pharmaceutical Co, Ltd.......143
Table 141: Market Shares of Leading Third-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Gan & Lee Pharmaceutical, Ltd., Novo Nordisk, and Sanofi S.A.......144
Table 142: Market Shares of Leading Human Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Eli Lilly and Company India Pvt. Ltd., Novo Nordisk India Limited, Sanofi India Limited, Wockhardt Ltd., and Others......145
Prescription Drugs......146
Table 143: Market Shares of Leading Prescription Drug Companies in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries, Ltd., and Others......146
Table 144: Market Shares of Leading Prescription Drug Companies Spending through Media Ads in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......147
Table 145: Market Shares of Leading Prescription Pharmaceutical Companies in the US (2014) - Percentage Market Share Breakdown by Volume Sales for Actavis Plc, Amneal, Inc., Endo Pharma, Inc., Lupin Pharmaceuticals, Inc., Mylan Labs,Inc., Novartis International AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and Others......148
Table 146: Market Shares of Leading RX Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Eurofarma Laboratórios, Hypermarcas S.A.,Pfizer, Inc., Roche AG, Sanofi - Medley Indústria Farmacêutica Ltda and Others......149
Drug Eluting Stents (DES)......150
Table 147: Market Shares of Leading Drug Eluting Stent (DES) Brands Worldwide (2014) - Percentage Share Breakdown by Value Sales for Endeavor, Promus, Taxus, Xience V, and Others......150
Table 148: Market Shares of Leading Drug Eluting Stent Manufacturers by Value Sales in Japan (2014) - Percentage Breakdown for Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, and Others......151
Table 149: Market Shares of Leading Drug Eluting Stent Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Abbott Laboratories, Boston Scientific Corporation, Johnson & Johnson, and Medtronic, Inc.......152
Table 150: Market Shares of Leading Drug Eluting Stents (DES) Manufacturers by Value Sales in China (2014) - Percentage Breakdown for Lepu Medical Technology (Beijing) Co., Ltd., MicroPort Scientific Corporation, and Others......153
Other Drugs......154
Table 151: Market Shares of Leading Affordable Medicines Facility Malaria (AMFm) Manufacturers by Value Sales Worldwide (2015) - Percentage Breakdown for Ajanta Pharma Limited, Cipla Limited, Ipca Laboratories, Novartis AG, Strides Arcolab Limited, and Others......154
Table 152: Market Shares of Leading Albumin Providers in China (2014) - Percentage Breakdown by Value for Baxter International, Inc., China Biologic Products, Inc., China National Biotec Group (CNBG), CSL Behring, Grifols, S.A., Hualan Biological Engineering, Inc., Jiangsu Kangbao Medical Equipment Co, Ltd., Ningbo Shuanglin Mould Co, Ltd., Octapharma AG, Shanghai RAAS Blood Products Co, Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co, Ltd., Tonrol Biopharm Co, Ltd., and Others......155
Table 153: Market Shares of Leading Artemisinin-based Combination Therapies (ACT) Manufacturers by Value Sales Worldwide (2015) - Percentage Breakdown for Ajanta Pharma Limited, Cipla Limited, Guilin Pharmaceutical Co., Ltd, Ipca Laboratories, Novartis AG, Quality Pharma Products Pvt Ltd, Sanofi S.A., and Sigma Pharmaceuticals Limited......156
Table 154: Market Shares of Leading Clinical Research Organization (CRO) Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Charles River Laboratories International, Inc., Covance, Inc., ICON Plc, INC Research, Inventiv Health, Inc., Laboratory Corporation of America Holdings, PAREXEL International, Pharmaceutical Product Development LLC, PRA International, Quest Diagnostics, Inc., Quintiles Transnational Holdings, Inc., Wuxi Pharmatech (Cayman) Inc., and Others......157
Table 155: Market Shares of Leading Fractionators (With Recombinant Factors) Worldwide (2014) - Percentage Breakdown by Value for Baxter International, Inc., Biotest Pharmaceuticals Corporation, CSL, Ltd., Kedrion Biopharma, LFB Group, Octapharma AG, Talecris Plasma Resources (Grifols, Inc.), and Others......158
Table 156: Market Shares of Leading Fractionators (Without Recombinant Factor) Worldwide (2014) - Percentage Breakdown by Value for Baxter International, Inc., Biotest Pharmaceuticals Corporation, CSL, Ltd., Kedrion Biopharma, LFB Group, Octapharma AG, Talecris Plasma Resources (Grifols, Inc.), and Others......159
Table 157: Market Shares of Leading Fractionators in China (2014) - Percentage Breakdown by Value for Baxter International, Inc., China Biologic Products, Inc., China National Biotec Group, CSL Behring, Grifols, S.A., Hualan Biological Engineering, Inc., Jiangsu Kangbao Medical Equipment Co, Ltd., Ningbo Boya Medical Equipment Co, Ltd., Ningbo Shuanglin Mould Co, Ltd., Octapharma AG, Shanghai RAAS Blood Products Co, Ltd., Shuyang Group, Tonrol Biopharm Co, Ltd., and Others......160
Table 158: Market Shares of Leading Gadeopentetate Dimengulumine Injection Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Bayer HealthCare AG, Beijing BeiLu Pharmaceutical Co., Ltd., Consun Pharmaceutical Group Ltd., General Electric Company, Shanghai Xudong Haipu Pharmaceutical Co., Ltd. and Others......161
Table 159: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Baxter International, Inc., Biotest AG, CSL Ltd., Grifols, S.A., Kedrion S.p.A., Octapharma AG and Others......162
Table 160: Market Shares of Leading Cardio-Cerebral Vascular (CCV) Drugs Manufacturers in China (2015)-Percentage Share Breakdown by Value for Sihuan Pharmaceutical Holdings Group Ltd, Sanofi S.A., Qilu pharmaceutical Co, Ltd. and Others......163
Table 161: BTG Plc's Sales in Acute Care Segment by Drug Worldwide (2014) - Percentage Share Breakdown by Value Sales for CroFab, DigiFab and Voraxaze......164
Table 162: BTG Plc's Sales by Segment Worldwide (2014) - Percentage Market Share Breakdown by Value for Acute Care, Biocompati Bles, Royalty Revenue and Varisolve......165